Spice drugs are more than harmless herbal blends: A review of the pharmacology and toxicology of synthetic cannabinoids

  title={Spice drugs are more than harmless herbal blends: A review of the pharmacology and toxicology of synthetic cannabinoids},
  author={Kathryn A. Seely and Jeff M Lapoint and Jeffery H. Moran and Liana Fattore},
  journal={Progress in Neuro-Psychopharmacology and Biological Psychiatry},

Figures and Tables from this paper

Synthetic cannabinoids: the hidden side of Spice drugs

Insight is gained into the epidemiological, pharmacological and toxicological properties of synthetic cannabinoids, aiming to provide a reliable background needed for the management of synthetic cannabinoid-related adverse effects.

New designer drugs (synthetic cannabinoids and synthetic cathinones): review of literature.

The absence of legal risks, the ease of obtaining these drugs, the moderate cost, and the availability via the Internet are the main features that attract users, but the number of intoxicated people presenting with emergencies is increasing.

Update: Drug-Related Emergency Department Visits Involving Synthetic Cannabinoids

They are labeled “not for human consumption” to mask their intended purpose and avoid Food and Drug Administration (FDA) regulatory oversight of the manufacturing process.

The K2/Spice Phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products

This review comprehensively describes the emergence of SCB abuse and provides a historical account of the major case reports, legal decisions and scientific discoveries of the “K2/Spice Phenomenon”.

Pharmacological and Toxicological Effects of Phytocannabinoids and Recreational Synthetic Cannabinoids: Increasing Risk of Public Health

The present review aims to provide a focused overview of the literature concerning the development of synthetic CBs, their abuse, and potential toxicological effects including renal toxicity, respiratory depression, hyperemesis syndrome, cardiovascular effects, and a range of effects on brain function.

How Does Synthetic Marijuana (K2) Mimic the Effects of Naturally Occurring Chemical Compound Found in THC

This paper investigates how synthetic marijuana (K2) mimics the effects of the naturally occurring chemical found in Δ9-THC, the two major chemical compounds contained in Marijuana.

Baths Salts, Spice, and Related Designer Drugs: The Science Behind the Headlines

A brief up-to-date review describing the mechanisms of action and neurobiological effects of synthetic cathinones and cannabinoids is provided.


This study aimed to present a general approach to synthetic cannabinoids, which are difficult to detect and identify because they do not show cross-reactivity in drug test assays.



[Spice drugs: cannabinoids as a new designer drugs].

Some smokable herbal mixtures under the brand name Spice drugs have been sold on the Internet and in specialised shops (smart shops) since 2004 and can be considered as new products to be added to the list of 'designer drugs'.

A survey study to characterize use of Spice products (synthetic cannabinoids).

The emergence and analysis of synthetic cannabinoids.

Background information in the style of a brief monograph is included, as an aid to rapidly understanding the pharmacological aspects of these compounds in the forensic context, and a comprehensive set of data is presented, obtained from analysis of purchased products by gas chromatography-mass spectrometry (GC-MS) and liquid Chromatography-tandem mass spectromaetry (LC-MS/MS).

Beyond THC: The New Generation of Cannabinoid Designer Drugs

An escalating number of compounds with cannabinoid receptor activity are currently being found as ingredients of Spice, of which almost nothing is known in terms of pharmacology, toxicology, and safety.

Screening for the synthetic cannabinoid JWH-018 and its major metabolites in human doping controls.

A urine sample of a healthy man declaring to have smoked a 'spice' product was screened for potential phase-I and -II metabolites by high-resolution/high-accuracy mass spectrometry and demonstrated its capability for a sensitive and selective identification of JWH-018 and its metabolites in human urine.

Synthetic cannabinoid JWH-018 and psychosis: an explorative study.

Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds.

The identification of the synthetic opioid O-desmethyltramadol in a herbal mixture declared to contain 'kratom' proves that the concept of selling apparently natural products spiked with potentially dangerous synthetic chemicals/pharmaceuticals is a continuing trend on the market of 'legal highs'.

Pharmacology and toxicology of Cannabis derivatives and endocannabinoid agonists.

The present article review recent study and patents with focus on the cannabinoid system as a target for the treatment of central nervous system disorders with emphasis on agonists.

Myocardial Infarction Associated With Use of the Synthetic Cannabinoid K2

The first (to the authors' knowledge) cases of myocardial infarction after smoking K2 are reported, and public education and awareness need to be heightened about the possible health implications of K2.